Adverse drug reactions to first-line antituberculosis drugs at four DOTS centers in Goa, India

Rupchandra Navelkar, I. Pereira, F. Vaz
{"title":"Adverse drug reactions to first-line antituberculosis drugs at four DOTS centers in Goa, India","authors":"Rupchandra Navelkar, I. Pereira, F. Vaz","doi":"10.4103/kleuhsj.kleuhsj_184_22","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Major adverse drug reactions (ADRs) can cause significant morbidity and can compromise the treatment regimen. This can result in substantial additional cost due to added outpatient visits to the health facility or laboratory investigations or hospitalization in serious instances. Treatment is often prolonged with additional challenge of compliance. Hence, there is a need to monitor and manage these ADRs timely for better patient care and outcome. This study was carried out with the objective of studying the pattern of ADRs due to first-line antitubercular drugs and to carry out the causality and severity assessment of the reported ADRs. METHODOLOGY: A prospective observational study was conducted at four DOTS centers. All tuberculosis (TB) patients registered and receiving treatment under DOTS were enrolled for the study and were followed up at regular intervals till the end of their treatment. Patients' demographic, personal, disease, investigation, and ADRs details were entered in a predesigned patient recording form. Causality assessment of all ADRs were done using Naranjo algorithm. Severity assessment was done using modified Hartwig and Siegel scale. The study was approved by the institutional ethics committee of the institute. Statistical analysis was conducted using IBM SPSS Statistics for Windows. RESULTS: Of 186 patients, 23 patients (12.26%) developed one or more ADRs. The average number of ADRs per person was 1.43. Majority of the ADRs were reported in the 20–40 years of age group and ADRs were more likely to be among females compared to males. There was no association between type of TB, site of TB, regimen of anti-TB drugs, treatment outcomes, and ADRs. Around 84.85% and 15.15% of ADRs were classified as of mild and moderate severity, respectively, as per modified Hartwig and Siegel scale, while, as per Naranjo algorithm, 72.73% of the ADRs were classified as probable and 27.27% of ADRs as possible. No ADRs were classified as definite. CONCLUSION: Thorough understanding of the various ADRs and their management will help in the effective treatment of TB as well as designing effective counseling methods, which will help in adherence to treatment and also to have better compliance.","PeriodicalId":13457,"journal":{"name":"Indian Journal of Health Sciences and Biomedical Research (KLEU)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Health Sciences and Biomedical Research (KLEU)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/kleuhsj.kleuhsj_184_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND: Major adverse drug reactions (ADRs) can cause significant morbidity and can compromise the treatment regimen. This can result in substantial additional cost due to added outpatient visits to the health facility or laboratory investigations or hospitalization in serious instances. Treatment is often prolonged with additional challenge of compliance. Hence, there is a need to monitor and manage these ADRs timely for better patient care and outcome. This study was carried out with the objective of studying the pattern of ADRs due to first-line antitubercular drugs and to carry out the causality and severity assessment of the reported ADRs. METHODOLOGY: A prospective observational study was conducted at four DOTS centers. All tuberculosis (TB) patients registered and receiving treatment under DOTS were enrolled for the study and were followed up at regular intervals till the end of their treatment. Patients' demographic, personal, disease, investigation, and ADRs details were entered in a predesigned patient recording form. Causality assessment of all ADRs were done using Naranjo algorithm. Severity assessment was done using modified Hartwig and Siegel scale. The study was approved by the institutional ethics committee of the institute. Statistical analysis was conducted using IBM SPSS Statistics for Windows. RESULTS: Of 186 patients, 23 patients (12.26%) developed one or more ADRs. The average number of ADRs per person was 1.43. Majority of the ADRs were reported in the 20–40 years of age group and ADRs were more likely to be among females compared to males. There was no association between type of TB, site of TB, regimen of anti-TB drugs, treatment outcomes, and ADRs. Around 84.85% and 15.15% of ADRs were classified as of mild and moderate severity, respectively, as per modified Hartwig and Siegel scale, while, as per Naranjo algorithm, 72.73% of the ADRs were classified as probable and 27.27% of ADRs as possible. No ADRs were classified as definite. CONCLUSION: Thorough understanding of the various ADRs and their management will help in the effective treatment of TB as well as designing effective counseling methods, which will help in adherence to treatment and also to have better compliance.
印度果阿四个DOTS中心对一线抗结核药物的不良反应
背景:主要的药物不良反应(adr)可导致显著的发病率,并可能危及治疗方案。这可能导致大量额外费用,因为增加了对卫生设施的门诊访问或实验室检查,或在严重情况下住院。治疗通常会延长,并带来额外的依从性挑战。因此,有必要及时监测和管理这些不良反应,以获得更好的患者护理和结果。本研究的目的是研究一线抗结核药物引起的不良反应模式,并对报告的不良反应进行因果关系和严重程度评估。方法:在四个DOTS中心进行前瞻性观察研究。所有登记并在DOTS下接受治疗的结核病患者都参加了这项研究,并定期随访,直到治疗结束。患者的人口统计、个人、疾病、调查和不良反应的详细信息输入到预先设计的患者记录表格中。所有不良反应的因果关系评价采用Naranjo算法。采用改良的Hartwig和Siegel量表进行严重程度评估。该研究得到了该研究所机构伦理委员会的批准。采用IBM SPSS Statistics for Windows进行统计分析。结果:186例患者中,23例(12.26%)出现一种或多种不良反应。人均adr数量为1.43。大多数不良反应报告发生在20-40岁年龄组,与男性相比,女性更容易发生不良反应。结核类型、结核部位、抗结核药物方案、治疗结果和不良反应之间没有关联。根据改进的Hartwig和Siegel量表,分别有84.85%和15.15%的adr被划分为轻度和中度,而根据Naranjo算法,72.73%的adr被划分为可能adr, 27.27%的adr被划分为可能adr。没有adr被归类为明确的。结论:深入了解各种不良反应及其管理,有助于有效治疗结核病,设计有效的咨询方法,有助于患者坚持治疗,提高依从性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
56
审稿时长
32 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信